| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Dermatologic Side Effects Associated with Gefitinib Therapy: Clinical Experience and Management
|
Herbst, Roy S.
|
|
2003
|
4 |
6 |
p. 366-369
4 p.
|
artikel
|
| 2 |
Erlotinib (OSI-774, Tarceva™), a Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Combination with Chemotherapy for Advanced Non–Small-Cell Lung Cancer
|
Hightower, Mary
|
|
2003
|
4 |
6 |
p. 336-338
3 p.
|
artikel
|
| 3 |
Gefitinib in the Treatment of Advanced, Refractory Non–Small-Cell Lung Cancer: Results in 124 Patients
|
Hainsworth, John D.
|
|
2003
|
4 |
6 |
p. 347-355
9 p.
|
artikel
|
| 4 |
2002 Highlights From: 14th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; Frankfurt, Germany November 19–22, 2002
|
Hightower, Mary
|
|
2003
|
4 |
6 |
p. 333-335
3 p.
|
artikel
|
| 5 |
Radiation Dose Intensification in Limited-Stage Small-Cell Lung Cancer
|
Roof, Kevin S.
|
|
2003
|
4 |
6 |
p. 339-346
8 p.
|
artikel
|
| 6 |
Role of Cyclooxygenase-2 Inhibitors in Combination with Radiation Therapy in Lung Cancer
|
Liao, Zhongxing
|
|
2003
|
4 |
6 |
p. 356-365
10 p.
|
artikel
|
Tijdschrift beschrijving